I would like more information about the Taxotere Lawsuit
Ready to Talk?
# Taxotere Lawsuit
Women around the country are learning that their permanent hair loss is anything but a coincidence. Instead, Taxotere manufacturers may have known all along about the danger of permanent hair loss and kept it quiet, even when other treatment options were available.
Were you given the truth about Taxotere or the generic version of Taxotere called Docetaxel, you could have made an honest decision, with the facts. That decision would have been yours, your choice. But to have a permanent reminder of your cancer, all because of a chemo drug that likely could have just as easily been traded out for another drug? That wasn’t okay and we are so, so sorry.
We’re talking to women NOW who were hurt. You may have legal options but time is running out to take action. If you were hurt, contact us to learn your Taxotere lawsuit rights before it is too late!
W e’ve got good news and bad news. Good news is the FDA issued a black box warning for Taxotere, the most severe form of FDA warning there is. That should help a whole lot of women and doctors understand the risks associated with Taxotere, before they potentially begin treatment.
Bad news is the warning, also called a “boxed warning” as it’s placed directly on the product’s packaging, will certainly not take the suffering away from women already hurt by Taxotere.
In fact, the boxed warning may affect women’s statutes, meaning: You may have very little time left to take legal action if you were hurt!
There’s nothing quite like a powerful pharma company hiding need-to-know information from a vulnerable group and potentially making billions in return. Here’s the scoop:
Taxotere and its generic version Docetaxel: No indication that’s it’s any more effective than comparable chemo drugs on the market and a strong risk of one potentially permanent side effect — all over, full body hair loss or balding.
Meanwhile, “The Other Drugs:” hair loss may occur during chemotherapy but hair tends to regrow soon after treatment.
So why weren’t you told the difference?
You know how it goes, because we’ve heard this story before. Taxotere costs patients more than a pretty penny, and it made its manufacturer a fortune. So for twenty years, things kept chugging. Women were prescribed Taxotere, not told the risk of permanent hair loss. Doctors prescribed Taxotere, not told the risk of permanent hair loss. And meanwhile there may have always been a less expensive, equally effective option — with no permanent reminder of your cancer included.
Maddening, right? You bet. That’s why we’re women helping women learn their legal options. Change won’t come unless we speak up to power and say NO MORE! If you were hurt, take action.
At the end of the day, this is about your right to choose and look after your body — at the most critical time. When you were already fighting cancer with all you had, Taxotere may have just dug that knife in deeper — and WHY?
A Case for Women’s Taxotere initiative is sponsored by the law firm of Fears Nachawati, PLLC and Carino Law LLC, 154-59 23rd Avenue, Whitestone, NY 11357, (718) 321-3538. These firms may be affiliated with select other A Case for Women initiatives.
Fears Nachawati is headquartered in Dallas, TX and Carino Law is headquartered in New York City, New York.
Attorney Advertising. The contents of this website should not be construed as legal advice and the receipt of such information does not create an attorney-client relationship. Additionally, prior results do not guarantee future outcomes.
If there is no recovery (compensation), no fees or costs are charged by these law firms!